NASH trials recruiting in Connecticut

All NASH trials nationally

Cities in Connecticut

Recruiting trials in Connecticut

• A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
  NCT07165028 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Connecticut: Hamden
• A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
  NCT06528314 · Phase: Phase 3 · Ages: 18 Years to 80 Years · Sex: All (male and female) · Connecticut: New Haven
• A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
  NCT06215716 · Phase: Phase 3 · Ages: 18 Years to 80 Years · Sex: All (male and female) · Connecticut: New Haven
• Digoxin In NASH (CODIN)
  NCT06588699 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Connecticut: New Haven
• LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
  NCT06632457 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Connecticut: Bristol
• LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
  NCT06632444 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Connecticut: Bristol, New Haven
• Pathogenesis of Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)
  NCT04634643 · Phase: Not specified · Ages: 12 Years to 18 Years · Sex: All (male and female) · Connecticut: New Haven
• Reversal of Lipid-Induced Insulin Resistance
  NCT02193295 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 90 Years · Sex: All (male and female) · Connecticut: New Haven